Contrast Enhanced Ultrasound Market Outlook (2022-2033)

Rising Prevalence of Chronic Diseases & Clinical Need for Non-Invasive Imaging

The rising incidence of chronic diseases globally, particularly cardiovascular disorders, liver diseases, and cancers, is one of the principal factors propelling the contrast enhanced ultrasound market. This situation slices up the demand for advanced diagnostic imaging tools into very large pieces as the diseases are still incurring and killing up to 17.9 million people per year worldwide. Along the way, the need for accurate, repeatable diagnostics that come without the risk of radiation exposure is becoming critical. CEUS is safe to use because it does not emit ionizing radiation and at the same time offers real-time visualization of blood flow and tissue perfusion. Therefore, it is accommodative for regular disease monitoring, lesion characterization, and treatment evaluation. Its application is noted in the clinical guidelines for liver cancer diagnostics when CT/MRI are inconclusive, thus further confirming CEUS's involvement in the management of chronic conditions. Adoption is also influenced by the growing demand for radiation-free, cost-effective imaging that improves patient safety and outcomes, hence CEUS is put in the spotlight as a favored modality in contemporary diagnostic pathways.

Integration of AI & Expansion into Emerging Clinical Applications

The contrast enhanced ultrasound market has a technology integration and a wider range of clinical applications as the main factors driving its growth. Among these applications, artificial intelligence (AI) and machine learning are the most promising ones. The latest news indicates that going forward, AI will be incorporated into medical imaging software and ultrasound platforms for diagnosis by means of better accuracy with less human intervention, and on-the-spot support giving, thus, increasing clinical usefulness and streamlining the process. The result is that development is now being done through investment and collaborations, one of the examples being the partnerships between makers of imaging devices and AI researchers to work on the next-gen ultrasonic devices. Besides that, the use of ultrasonic imaging in children, cancer patients, and the emergency room or doctor's office has increased, and CEUS use in such cases is going to be very safe, accurate, and less harmful (compared to CT/MRI), especially because it is targeted at vulnerable groups. The regulators are also opening up to the New and Advanced CEUS technologies more and more in the recent times which is resulting in fast tracking of approvals and thus around for the broader clinical use. The emerging markets in Asia-Pacific, Latin America, and the Middle East & Africa are also putting money into healthcare infrastructure and CEUS adoption, which indicates the growth potential of the said regions as they will be the first ones to have the non-invasive imaging methods.

The " Contrast Enhanced Ultrasound Market Size and Forecast (2022 - 2033)" report provides a detailed analysis of the market covering below areas:

• Contrast enhanced ultrasound market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Contrast enhanced ultrasound market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Contrast enhanced ultrasound market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the contrast enhanced ultrasound market
• Detailed company profiles, including SWOT analysis

The geographical scope of the contrast enhanced ultrasound market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The contrast enhanced ultrasound market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific contrast enhanced ultrasound market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The Asia-Pacific contrast enhanced ultrasound market is experiencing robust growth, due to several interconnected factors that are transforming healthcare delivery and diagnostic imaging adoption. The modernization of healthcare infrastructure in major countries such as China, India, and Japan is developing rapidly and is leading to the opening of new doors as far as advanced imaging modalities are concerned with more hospitals and diagnostic centers to incorporate CEUS into daily practice. Continuous increase in chronic disease cases like cancer, liver ailments, and heart diseases calls for very accurate and gentle diagnostic tools, particularly for assessing blood vessels and organs in real-time. The APAC population is getting larger and older, which in turn, is pushing the need for imaging that is done frequently and is safe, and the no-radiation profile of CEUS makes it very appealing. Governments in this area are not only increasing the healthcare budget but also changing the regulations to promote the use of advanced diagnostic technologies, while public-private partnerships and local production are making CEUS systems and contrast agents more accessible and affordable. Furthermore, the growing significance of point-of-care imaging and ultrasound training for clinicians is helping to improve the acceptance and use of the technology in the region thereby contributing to its being the fastest-growing CEUS market in the world.

• The report includes qualitative and quantitative data in the contrast enhanced ultrasound market across product, type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the contrast enhanced ultrasound market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the contrast enhanced ultrasound market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the contrast enhanced ultrasound market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover contrast enhanced ultrasound market segments by product, type, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the contrast enhanced ultrasound market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The contrast enhanced ultrasound market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the contrast enhanced ultrasound market are:

• In September 2023, GE HealthCare announced it received a grant from the Bill & Melinda Gates Foundation for more than US$44 million to create user-friendly, AI-assisted ultrasound imaging auto-assessment tools. The intent of these tools is to assist healthcare providers—also those without the necessary training or experience in ultrasound—by giving them clinical decision support, thereby improving obstetric and lung screening ultrasound scans in maternal and fetal care, as well as in pediatric lung health, with the aim of increasing access to low-and-middle income countries (LMIC) and various care locations.
• In March 2024, at the European Congress of Radiology 2024 (ECR 2024) held in Vienna, Austria in February 2024, Samsung Medison and Bracco Imaging agreed to a Memorandum of Understanding (MoU) that would mark the start of a new path for the diagnostic ultrasound device and contrast agent. This MoU aims to generate synergy in research and development and market exploration through the uniting of the skills and marketing power of Samsung Medison, one of the world's top producers of innovative high-end ultrasound diagnostic machines, and Bracco Imaging, a technology-driven global leader providing end-to-end products and solutions through a wide-ranging portfolio that includes precision diagnostic imaging modalities.